![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2009 Okiro et al; licensee BioMed Central Ltd. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity 1Malaria Public Health and Epidemiology Group, Centre for Geographic Medicine, KEMRI-Wellcome Trust Collaborative Programme, Kenyatta National Hospital Grounds P.O. Box 43640-00100, Nairobi, Kenya 2Faculty of Medicine and Health Sciences, Sana'a University, P.O. Box 13078, Sana'a, Yemen 3London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK 4Kilimanjaro Christian Medical Centre P.O. Box 2228 Moshi, Tanzania 5Department of Paediatrics, Mulago Hospital/Makerere University Medical School Kampala, Uganda 6Kenya Medical Research Institute, Centre for Geographic Medicine Research – Coast, Kilifi, Kenya P.O. Box 230-80108, Kilifi, Kenya 7Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, CCVTM, Oxford, OX3 9DS, UK Corresponding author.Emelda A Okiro: eokiro/at/nairobi.kemri-wellcome.org; Abdullah Al-Taiar: a_m_altaiar/at/yahoo.com; Hugh Reyburn: Hugh.Reyburn/at/lshtm.ac.uk; Richard Idro: ridro/at/kilifi.kemri-wellcome.org; James A Berkley: jberkley/at/kilifi.kemri-wellcome.org; Robert W Snow: rsnow/at/nairobi.kemri-wellcome.org Received November 5, 2008; Accepted January 7, 2009. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Background The understanding of the epidemiology of severe malaria in African children remains incomplete across the spectrum of Plasmodium falciparum transmission intensities through which communities might expect to transition, as intervention coverage expands. Methods Paediatric admission data were assembled from 13 hospitals serving 17 communities between 1990 and 2007. Estimates of Plasmodium falciparum transmission intensity in these communities were assembled to be spatially and temporally congruent to the clinical admission data. The analysis focused on the relationships between community derived parasite prevalence and the age and clinical presentation of paediatric malaria in children aged 0–9 years admitted to hospital. Results As transmission intensity declined a greater proportion of malaria admissions were in older children. There was a strong linear relationship between increasing transmission intensity and the proportion of paediatric malaria admissions that were infants (R2 = 0.73, p < 0.001). Cerebral malaria was reported among 4% and severe malaria anaemia among 17% of all malaria admissions. At higher transmission intensity cerebral malaria was a less common presentation compared to lower transmission sites. There was no obvious relationship between the proportions of children with severe malaria anaemia and transmission intensity. Conclusion As the intensity of malaria transmission declines in Africa through the scaling up of insecticide-treated nets and other vector control measures a focus of disease prevention among very young children becomes less appropriate. The understanding of the relationship between parasite exposure and patterns of disease risk should be used to adapt malaria control strategies in different epidemiological settings. Background During the 1980's and 1990's a series of epidemiological observations were reported on the age and clinical patterns of severe malaria in African children across a range of Plasmodium falciparum transmission intensities [1-4]. It appeared from these early observations that the intensity of transmission affected the mean age and clinical features of severe disease and rates of disease showed a nonlinear relationship with transmission intensity, stimulating much heated debate and commentary [5-9]. Subsequent to these earlier studies there has been a renaissance in the clinical epidemiology of severe paediatric malaria across a wide range of different transmission settings, leading to descriptions of severe paediatric malaria from Sudan [10], Mozambique [11], Tanzania [12,13], Mali [14], Niger [15], Kenya [16], Uganda [17,18], Yemen [19], Ghana [20,21] and Zambia [22]. In addition, there have been several further attempts to compare the epidemiological patterns of severe malaria between sites of different transmission intensity in Gabon [23], Burkina Faso [24], Uganda [17], Sudan [25], Tanzania versus Mozambique [26], and one study that compared severe malaria risks at different altitudinal transmission limits in Tanzania [13]. The consensus view of all studies is that as the intensity of P. falciparum transmission increases, the mean age of severe malaria decreases. Less consistent is the reported relationship between clinical syndromes of severe paediatric malaria and transmission intensity. There are three limitations of many of the reported ecological comparisons. First, they often compare data from very few sites, reducing the contextual ranges of the observations and thus their wider validity. Second, the measures of transmission intensity used in most studies are often imperfect or assumed rather than measured [13,17,23,25]; or not matched to the period of clinical surveillance under review [11,26]. Finally, despite an increased number of observational studies of severe malaria, they often do not cover the same age range, nor do they use similar diagnosis and surveillance methods. To circumvent some of these limitations of cross-site comparisons and increase the power to generalize from observations, data from 17 sites across seven countries are presented. The standardization of metrics used to define transmission intensity in each site have significantly improved, have been temporally matched to the clinical surveillance period and attempts have been made to ensure standardization in surveillance and diagnostic methods between survey observations, to examine the relationship between age patterns of hospitalized paediatric malaria and P. falciparum transmission intensity. Methods Clinical surveillance In this review we have assembled clinical admission data from 17 communities served by 13 hospitals. The surveillance sites were selected on the basis of having established clinical and parasitological surveillance, often to specifically study the pathophysiology, management and epidemiology of severe paediatric malaria. Study sites The 17 communities represent a wide range of malaria ecology typical of the P. falciparum endemic world (Figure (Figure1,1
Surveillance and diagnosis At each hospital all paediatric admissions routinely undergo a screening procedure where symptom histories are recorded. the definition of paediatric is restricted to children aged less than ten years. Each child was examined on admission and a blood sample taken for malaria parasitology and haematology. Diagnosis was supported by detailed clinical examination; all clinical and laboratory data are reviewed by investigating physicians who established a primary diagnosis (defined as the principal reason for the child's admission). A primary diagnosis of malaria was made when a child had a positive blood smear and no other detectable cause for the clinical presentation, after a review of all available clinical and haematological data and where indicated, X-ray and microbiological data. Two clinically important complications of severe malaria in African children are cerebral malaria and severe malarial anaemia [29,30]. Consciousness on admission is recorded at most sites according to the Blantyre Coma Score (BCS) based on verbal, motor, and gaze responses to stimulation [29,31]. To allow comparison across studies a BCS of 0, 1, or 2 (4 or 5 considered normal depending on age [29]) was used to define coma and cerebral malaria in the presence of malaria infection and absence of other causes for the clinical presentation. In Kabale, a BCS of ≤ 2 was used to describe cerebral malaria in children aged less than 5 years old and a Glasgow Coma score [32] of ≤ 8 for children 5–9 years Severe malaria anaemia was defined as a diagnosis of malaria with an admission haemoglobin level of less than 5.0 g/dl or PCV of less than 15%. Plasmodium falciparum transmission intensity Cross-sectional estimates of P. falciparum infection prevalence from the communities served by the study hospital sites were assembled from information available as part of The Malaria Atlas Project [33] database [34,35]. Infection prevalence estimates were identified where they were spatially congruent, within 20 km of the hospital (Authors, unpublished data), and temporally congruent, during the years of the hospital surveillance. This restriction increases the accuracy of assigning transmission intensity to each of the clinical admission series. For each series of parasite prevalence survey data, the age-ranges reported varied between surveys and these were standardized to a single age range 2–10 years (PfPR2–10) using algorithms described elsewhere [36]. Results The study series included a total of 11,446 children admitted to the 13 hospitals with a primary diagnosis of malaria confirmed by microscopy from the 17 communities covering a total of 17 survey years between 1990 and 2007 (Table 1, Figure Figure1).1 To examine the corresponding age-patterns of malaria admission against transmission intensity we computed the proportion of all malaria admissions by single years of age 0 to 9 years at each site, arranged in descending order of PfPR2–10 in Figure Figure2.2
For a number of reasons, that are expanded on in the discussion, the public health and intervention significance of clinical risks in infancy is of programmatic importance. Among the six communities where the PfPR2–10 estimate was ≥ 40%; approximately 40% of all malaria admissions were in children aged < 1 year. This compared with an average of 20% of all malaria admissions in infancy among the eight sites with a PfPR2–10 between 5 and 39%, and 10% of all admissions at the three sites where PfPR2–10 was recorded as < 5%. There is a direct and strong linear relationship between increasing PfPR2–10 and the proportion of paediatric malaria admissions that are infants (R2 = 0.73, p < 0.001; Figure Figure3a)3a
The observations summarized in Figure Figure22 The hospitals that routinely recorded unconsciousness using a BCS or anaemia on admission are shown in Table 1. Across this admission series of 10,642 and 10,742 cases of paediatric malaria respectively, cerebral malaria was reported among 4% and severe malaria anaemia among 17% of admissions. The relationship between the proportion of admissions presenting with cerebral malaria (BCS ≤ 2) and PfPR2–10 is shown in Figure Figure4a.4a
Discussion There is mounting evidence that the epidemiology of malaria infection and disease risks are in transition is some parts of Africa, in part as a result of scaling of the provision of insecticide treated nets (ITN) and adoption of new effective therapeutics [37-41]. How changing the natural risks of parasite exposure by vector control will alter the clinical epidemiology of severe, complicated disease in young African children was the subject of concern over 50 years ago [42,43] and interest in this area re-emerged ten years ago following early comparisons of the clinical outcomes of infection in different transmission settings [3,4,8,44]. There are very few serial, long-term clinical observations of severe paediatric malaria in areas where transmission intensity is in transition [41]. Thus to understand the relationships between transmission intensity and disease outcome we must default to cross-sectional estimations of risk and exposure from different settings to infer what might happen if single communities transitioned between exposure states. Ecological comparative observational epidemiology is not without its limitations. An attempt has been made to standardize observations across 17 communities to minimize methodological measurement differences in the study of the clinical epidemiology of hospitalized paediatric malaria and transmission. Here PfPR2–10 estimates of transmission contemporary with the clinical observations were used to ensure congruence between exposure and outcome. One of the most striking observations was the relationship between increasing transmission intensity and the predominant age of paediatric malaria admissions (Figures (Figures2,2 Despite the overall linear pattern of proportions of admissions aged less than one year (Figure (Figure3a)3a More importantly the differences in peak age of hospitalized malaria disease presentation and transmission intensity have implications for the design of suites of prevention strategies planned for the control of malaria in Africa. The benefit of targeted intervention in the use of bed nets for malaria control as currently recommended by the WHO is based on the reasoning that targeting bed nets to the highest risk groups; infants and pregnant women, achieves the highest public health impact. Following the same reasoning it is clear that the likely public health impact of intermittent presumptive treatment of infants (IPTi) coincidental with vaccine schedules [49], is likely to be greatest in areas of the transmission axis where the disease burden in concentrated in infancy (Figure (Figure3a).3a In this study series, cerebral malaria appeared to be a more common presentation among children hospitalized with malaria from lower intensity transmission settings compared to areas of high transmission (Figure (Figure4a).4a The incidence of hospitalization has not been examined, largely because the precise calculation of the paediatric populations at risk was not possible across most of the sites studied after the 1990's. Therefore, no specific comments on the overall changing risks of hospitalization as PfPR2–10 declines can be made. Nevertheless, it is interesting to note that the one long-term serial study of severe clinical malaria in Africa has investigated the rate of hospitalization during a time of major transmission reduction at Kilifi North [41]. O'Meara et al. (2008) showed that in this community, that began with a PfPR2–10 of approximately 50% and declined to 1% over ten years, resulted in a ten-fold decline in the risks of hospitalization with malaria in childhood. The focus here has been on better descriptions, across more sites of the age and clinical presentation of hospitalized malaria in childhood likely to be observed with reductions in transmission intensity across Africa as prevention strategies go to scale over the next ten years. Perhaps not surprisingly these results confirm many other observations, using less rigorous inclusion criteria [11,23,25], that declining transmission intensity will result in fewer infants and proportionately more children of older age groups as representing the clinical burdens facing hospitals in Africa. It is less certain whether the case-mix of cerebral malaria and severe malaria anaemia will change coincidental with declining transmission intensity. Competing interests The authors declare that they have no competing interests. Authors' contributions EA assembled all the hospital data, restructured the data and wrote the manuscript; AAT, HR, RI and JAB were responsible for the assembly of hospital data from Yemen, Tanzania, Uganda and Kilifi, Kenya respectively and contributed to the final manuscript. RWS was responsible for the project and its overall scientific management, interpretation and preparation of the final manuscript. Acknowledgements The following people generously helped with the provision of clinical and parasitological data presented in this paper and their interpretation: James Nokes, Geisler Snieder, Terrie Taylor and Edna Ogada. We thank Quique Bassat and Robert Opoka who provided comparative data which for various inclusion criteria reasons we were unable to include in this paper. We thank Simon Hay and Wendy O' Meara for helpful comments on earlier versions of the manuscript. RWS is supported by the Wellcome Trust as Principal Research Fellow (#079081). AAT was funded by UNICEF-UNDP-World Bank-WHO Special Programme for Research and Training in Tropical Diseases (TDR) (project ID: A30333 linked to project ID: A10491). HR was funded by Medical Research Council, UK (grant no. 9901439). JAB is supported by the Wellcome Trust as a Research Fellow (#083579). There are no competing interests. This work also forms an output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk) and is published with the permission of the director of KEMRI. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Trans R Soc Trop Med Hyg. 1987; 81 Suppl 2():34-42.
[Trans R Soc Trop Med Hyg. 1987]Parassitologia. 1999 Sep; 41(1-3):241-6.
[Parassitologia. 1999]Lancet. 1997 Aug 2; 350(9074):362.
[Lancet. 1997]Trends Parasitol. 2001 Mar; 17(3):145-9.
[Trends Parasitol. 2001]Trans R Soc Trop Med Hyg. 2005 Apr; 99(4):243-51.
[Trans R Soc Trop Med Hyg. 2005]Malar J. 2008 Feb 26; 7():37.
[Malar J. 2008]Am J Trop Med Hyg. 1999 Sep; 61(3):431-8.
[Am J Trop Med Hyg. 1999]JAMA. 2005 Mar 23; 293(12):1461-70.
[JAMA. 2005]Pediatr Infect Dis J. 2008 Feb; 27(2):130-5.
[Pediatr Infect Dis J. 2008]JAMA. 2005 Mar 23; 293(12):1461-70.
[JAMA. 2005]Trop Med Int Health. 2006 Jan; 11(1):115-24.
[Trop Med Int Health. 2006]Am J Trop Med Hyg. 2007 Dec; 77(6):1015-9.
[Am J Trop Med Hyg. 2007]East Mediterr Health J. 2006 Nov; 12(6):783-91.
[East Mediterr Health J. 2006]Malar J. 2008 Feb 26; 7():37.
[Malar J. 2008]Acta Trop. 1994 Sep; 57(4):289-300.
[Acta Trop. 1994]Lancet. 1997 Jun 7; 349(9066):1650-4.
[Lancet. 1997]East Afr Med J. 1997 Dec; 74(12):780-3.
[East Afr Med J. 1997]PLoS One. 2008 Mar 12; 3(3):e1767.
[PLoS One. 2008]JAMA. 2005 Mar 23; 293(12):1461-70.
[JAMA. 2005]Lancet. 1974 Jul 13; 2(7872):81-4.
[Lancet. 1974]N Engl J Med. 1995 May 25; 332(21):1399-404.
[N Engl J Med. 1995]Trans R Soc Trop Med Hyg. 2000 Apr; 94 Suppl 1():S1-90.
[Trans R Soc Trop Med Hyg. 2000]Q J Med. 1989 May; 71(265):441-59.
[Q J Med. 1989]Lancet. 1974 Jul 13; 2(7872):81-4.
[Lancet. 1974]PLoS Med. 2008 Feb; 5(2):e38.
[PLoS Med. 2008]Malar J. 2007 Feb 16; 6():17.
[Malar J. 2007]Malar J. 2007 Sep 25; 6():131.
[Malar J. 2007]Malar J. 2008 Jan 18; 7():15.
[Malar J. 2008]Am J Trop Med Hyg. 2008 Aug; 79(2):185-91.
[Am J Trop Med Hyg. 2008]Ann Trop Med Parasitol. 1949 Apr; 43(1):47-61.
[Ann Trop Med Parasitol. 1949]Trop Dis Bull. 1950 Aug; 47(8):677-98.
[Trop Dis Bull. 1950]Lancet. 1997 Jun 7; 349(9066):1650-4.
[Lancet. 1997]Am J Trop Med Hyg. 2008 Aug; 79(2):185-91.
[Am J Trop Med Hyg. 2008]Lancet. 1997 Jun 7; 349(9066):1650-4.
[Lancet. 1997]Parassitologia. 1999 Sep; 41(1-3):241-6.
[Parassitologia. 1999]Adv Parasitol. 2002; 52():235-64.
[Adv Parasitol. 2002]Nat Med. 1999 Mar; 5(3):340-3.
[Nat Med. 1999]J Infect Dis. 1998 Aug; 178(2):592-5.
[J Infect Dis. 1998]Proc Natl Acad Sci U S A. 2005 Apr 5; 102(14):5108-13.
[Proc Natl Acad Sci U S A. 2005]Trends Parasitol. 2006 Jul; 22(7):296-300.
[Trends Parasitol. 2006]Malar J. 2008 Jul 8; 7():123.
[Malar J. 2008]Trans R Soc Trop Med Hyg. 2008 Apr; 102(4):304-5.
[Trans R Soc Trop Med Hyg. 2008]Lancet Infect Dis. 2008 Jun; 8(6):369-78.
[Lancet Infect Dis. 2008]PLoS Med. 2008 Feb; 5(2):e38.
[PLoS Med. 2008]Acta Trop. 1994 Sep; 57(4):289-300.
[Acta Trop. 1994]Lancet. 1997 Jun 7; 349(9066):1650-4.
[Lancet. 1997]JAMA. 2005 Mar 23; 293(12):1461-70.
[JAMA. 2005]Trop Med Int Health. 2006 Jan; 11(1):115-24.
[Trop Med Int Health. 2006]Am J Trop Med Hyg. 1998 Oct; 59(4):539-42.
[Am J Trop Med Hyg. 1998]Am J Trop Med Hyg. 2008 Aug; 79(2):185-91.
[Am J Trop Med Hyg. 2008]Malar J. 2008 Feb 26; 7():37.
[Malar J. 2008]Am J Trop Med Hyg. 2007 Dec; 77(6):1015-9.
[Am J Trop Med Hyg. 2007]East Mediterr Health J. 2006 Nov; 12(6):783-91.
[East Mediterr Health J. 2006]